GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-κB Signaling Pathways

Autor: Ying-Jie Gao, Shoupeng Fu, Su-Nan Li, Juxiong Liu, Wen-Zhi Ren, Bo-Wen Liu, Wei Wang, Nan Li, Shi-Yao Xu, Yalong Zeng, Xuan Yan, Dianfeng Liu
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Lipopolysaccharides
0301 basic medicine
Gene Expression
Nitric Oxide Synthase Type II
microglia
NF-κB
lcsh:Chemistry
glucagon-like peptide-2
Parkinson’s disease
MAPK
chemistry.chemical_compound
GTP-Binding Protein alpha Subunits
Gs

Glucagon-Like Peptide 2
Phosphorylation
lcsh:QH301-705.5
Spectroscopy
Cell Line
Transformed

Microglia
NF-kappa B
General Medicine
Computer Science Applications
Cell biology
Nitric oxide synthase
medicine.anatomical_structure
Cytokines
Inflammation Mediators
medicine.symptom
Signal transduction
hormones
hormone substitutes
and hormone antagonists

Signal Transduction
endocrine system
MAP Kinase Signaling System
p38 mitogen-activated protein kinases
Inflammation
Biology
Article
Catalysis
Inorganic Chemistry
03 medical and health sciences
medicine
Animals
Mitogen-Activated Protein Kinase 9
Mitogen-Activated Protein Kinase 8
RNA
Messenger

Physical and Theoretical Chemistry
Molecular Biology
Organic Chemistry
Neurotoxicity
medicine.disease
030104 developmental biology
chemistry
lcsh:Biology (General)
lcsh:QD1-999
Cyclooxygenase 2
Immunology
biology.protein
Zdroj: International Journal of Molecular Sciences; Volume 17; Issue 2; Pages: 190
International Journal of Molecular Sciences, Vol 17, Iss 2, p 190 (2016)
International Journal of Molecular Sciences
ISSN: 1422-0067
DOI: 10.3390/ijms17020190
Popis: The pathogenesis of Parkinson’s disease (PD) often involves the over-activation of microglia. Over-activated microglia could produce several inflammatory mediators, which trigger excessive inflammation and ultimately cause dopaminergic neuron damage. Anti-inflammatory effects of glucagon-like peptide-2 (GLP-2) in the periphery have been shown. Nonetheless, it has not been illustrated in the brain. Thus, in this study, we aimed to understand the role of GLP-2 in microglia activation and to elucidate the underlying mechanisms. BV-2 cells were pretreated with GLP-2 and then stimulated by lipopolysaccharide (LPS). Cells were assessed for the responses of pro-inflammatory enzymes (iNOS and COX-2) and pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α); the related signaling pathways were evaluated by Western blotting. The rescue effect of GLP-2 on microglia-mediated neurotoxicity was also examined. The results showed that GLP-2 significantly reduced LPS-induced production of inducible nitric oxide synthase (iNOS), cyclooxygenase-s (COX-2), IL-1β, IL-6 and TNF-α. Blocking of Gαs by NF449 resulted in a loss of this anti-inflammatory effect in BV-2 cells. Analyses in signaling pathways demonstrated that GLP-2 reduced LPS-induced phosphorylation of ERK1/2, JNK1/2 and p65, while no effect was observed on p38 phosphorylation. In addition, GLP-2 could suppress microglia-mediated neurotoxicity. All results imply that GLP-2 inhibits LPS-induced microglia activation by collectively regulating ERK1/2, JNK1/2 and p65.
Databáze: OpenAIRE